Navigation Links
Glide Pharma Takes Exclusive Worldwide Rights to Novel Diagnostic Technology for Prostate Cancer
Date:7/29/2014

OXFORD, England, July 29, 2014 /PRNewswire/ --

 

Glide Pharmaceutical Technologies Ltd (Glide Pharma) today announced that it has taken an exclusive worldwide licence to an innovative prostate cancer diagnostic technology from FScan Ltd, a Durham University spin-out company.  Under the terms of the agreement, Glide Pharma will pay an upfront fee, development and commercial milestone payments, and royalties on future product sales.  Glide Pharma has also taken an option for additional exclusive licences to FScan diagnostic technologies, for use in other conditions.  

The licensed technology pioneers the use of lanthanide complexes for the non-invasive, rapid and accurate measurement of citrate levels in seminal fluid.  The link between citrate levels and prostate cancer is well documented, providing the opportunity to develop an effective diagnostic test.  Further clinical validation of this approach is currently underway in studies co-ordinated by Professor Mark Emberton, Consultant Urologist at University College London.

The current routinely-used prostate-specific antigen (PSA) diagnostic has major limitations, with inaccurate results leading to large numbers of patients undergoing unnecessary additional testing and biopsy.  A rapid, accurate, non-invasive test would meet a major unmet clinical need, and consequently has significant commercial potential.  Estimates suggest that approximately 24 million PSA tests are conducted each year in the US alone, with the worldwide market valued at more than $2 billion.  

Glide Pharma plans to provide the technology initially as an analyte specific reagent in the USA.  In the longer-term, the company intends to develop a prostate cancer diagnostic test, and to pursue regulatory approval in the US and Europe.
'/>"/>

SOURCE Glide Pharma
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Glide Pharma Completes Successful Proof-of-Concept Study with Novel Solid Dose Formulation of Octreotide
2. TriReme Medical and Japanese Partner Century Medical, Inc., Receive Shonin Approval for GliderXtreme PTA Catheter in Japan
3. Glide Pharma Completes £14.0 Million ($21.4 Million) Fundraising for Scale Up of Drug and Device Manufacturing Processes and Product Development
4. Verathon, maker of GlideScope video laryngoscopes, provides free educational DVD to promote best practices in pediatric airway management.
5. TriReme Medical, Inc. Receives FDA Approval for Glider™ PTCA Catheter
6. Pharmacyclics Announces Date of Conference call to discuss Financial Results for Second Quarter of 2014
7. Anthera Pharmaceuticals Reports 2014 Second Quarter Financial Results and Operational Update
8. Portugal Pharmaceuticals and Healthcare Report Q3 2014
9. Array BioPharma To Report Financial Results For The Fourth Quarter And Full Year Of Fiscal 2014 On August 12, 2014
10. Cardioxyl Pharmaceuticals Successfully Completes First Clinical Trial For Heart Failure Drug CXL-1427
11. ANI Pharmaceuticals Schedules Conference Call for Second Quarter 2014 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... , July 20, 2015 Research ... addition of the "Key Pharma News Issue" ... This acquisition bolsters Gilead Sciences, burgeoning oncology pipeline ... will make further oncology deals in 2015, with ... of 2016. Key Pharma News ...
(Date:7/27/2015)... Belgium , July 27, 2015 /PRNewswire/ ... life sciences company focused on developing blood-based diagnostic tests ... conditions, today announced that it has engaged the services ... Specimen Solutions, Inc. (GSS), to support initial U.S. market ... Under the agreement, GSS will target ...
(Date:7/27/2015)... , July 27, 2015 Syneron ... ) , a global market leader in the aesthetic ... Korean Ministry of Food and Drug Safety (MFDS) regulatory ... clearance, the Company can fulfill PicoWay orders from its ... Korea anticipated later in the third quarter 2015. ...
Breaking Medicine Technology:Key Pharma News Issue - Gilead will make further oncology deals in 2015 2Key Pharma News Issue - Gilead will make further oncology deals in 2015 3VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 2VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 3VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 4VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 5VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 6VolitionRx Engages Specialty Clinical Research Organization to Support Initial Entry of its NuQ(R) Colorectal Cancer Tests via U.S. CLIA Labs 7Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 2Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 3Syneron Receives Korean MFDS Regulatory Clearance for PicoWay Picosecond Laser 4
... Interventional Radiology Treatment Relieves Pain From Herniated Disks; ... but With Fewer Complications, Shorter Recovery TimeSAN DIEGO, ... treatment--that safely and effectively uses oxygen/ozone to relieve ... the United States in the next few years, ...
... Minimally Invasive "Lumpectomy" -- as Effective as Surgery -- ... Mapping Biopsy Changed Patients, Management 70 Percent of the ... -- a minimally invasive interventional radiology treatment for prostate ... diseased tumors and can be considered a first-line treatment ...
Cached Medicine Technology:Oh, My Aching Back: Give Me a Shot of Ozone 2Oh, My Aching Back: Give Me a Shot of Ozone 3Oh, My Aching Back: Give Me a Shot of Ozone 4Oh, My Aching Back: Give Me a Shot of Ozone 5Freezing Prostate Cancer Does a Man's Body Good 2Freezing Prostate Cancer Does a Man's Body Good 3Freezing Prostate Cancer Does a Man's Body Good 4Freezing Prostate Cancer Does a Man's Body Good 5Freezing Prostate Cancer Does a Man's Body Good 6Freezing Prostate Cancer Does a Man's Body Good 7
(Date:7/27/2015)... ... July 28, 2015 , ... Conducting Advanced Root ... to Improve the Quality of Investigations , **Presented by FDAnews and Learning Plus**, ... CAPAs have been the #1 reason for 483 observations since 1997! , The ...
(Date:7/27/2015)... NY (PRWEB) , ... July 28, 2015 , ... ... a 2015-2016 inductee into the NAPW VIP Woman of the Year Circle. She is ... and over 200 operating Local Chapters, NAPW is the nation’s leading networking organization exclusively ...
(Date:7/27/2015)... ... July 27, 2015 , ... ... science of the little-known and incurable disease, facioscapulohumeral muscular dystrophy (FSHD), today announced ... of Neurology (AAN). The FSHD care guideline is published today. , This ...
(Date:7/27/2015)... (PRWEB) , ... July 27, 2015 , ... North Central ... 2015. , The center invites all those prospective joint-replacement patients, along with their ... Thursday of each month, with Monday classes (Aug 6, Sept 8 [Tue due to ...
(Date:7/27/2015)... ... July 27, 2015 , ... ... is a professional and in-depth research report. The report provides basic information ... market analysis etc. This report covers the global (US, Europe, Japan etc) ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 2Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 3Health News:FDAnews Announces: Conducting Advanced Root Cause Analysis CAPA Investigations, Sept. 16-17, 2015, Raleigh, NC 4Health News:NAPW Inducts Jane Simmons, Counseling Intern at Omar Bradley Middle School of the Northeast Independent School District , Into its VIP Woman of the Year Circle 2Health News:First-Ever FSHD Evidence-based Care Guideline Published by the American Academy of Neurology 2Health News:North Central Surgical Center Hospital to Hold Joint Wellness Classes 2Health News:Calcium Propionate Market Global Suppliers and Manufacture Analysis 2Health News:Calcium Propionate Market Global Suppliers and Manufacture Analysis 3
... Address FDA,s Next Big Challenge, Is the Food ... Devices to Physicians and the Public?, WASHINGTON, Nov. ... device that repairs damaged cells and treats cancer through,electromagnetic ... its apparent connection to patient injuries and death. However,on ...
... - The Westaim Corporation,announced today that it has reached ... in Canadian third party asset-backed commercial paper (ABCP) with,a ... $6.0 million.,Westaim retains the right to receive additional proceeds ... six months; in such event, Westaim,will receive 50 per ...
... (Nasdaq: FLEX ),today announced that it will report ... earnings conference call, hosted by Flextronics,s senior,management, will be ... results,of the Company for its third quarter ended December ... via the Internet and may be,accessed by logging on ...
... may be undertreated compared to white patients, research suggests , ... likely than white women to suffer severe pain linked to ... than 1,100 patients in 19 countries. , The women -- ... given a pain test called the Brief Pain Inventory repeatedly ...
... Kocot and Robert,Seidman Headline Agenda at FDA/CMS Summit ... has,progressed beyond a topic of industry insider buzz ... and private payers. Value isn,t a new,concept in ... for buying and,selling biopharmaceuticals? How is value calculated, ...
... Nov. 26 Pharmasset, Inc.,(Nasdaq: VRUS ) ... & Sales, responsible for coordinating the global product ... Higgins, who,has served as a consultant to Pharmasset ... Virology at Hoffmann-LaRoche, Inc. His areas,of expertise include ...
Cached Medicine News:Health News:Food and Drug Law Institute Sponsors Colloquium on Communicating Risk/Safety Drug Information 2Health News:Westaim reduces ABCP exposure 2Health News:Flextronics to Report Third Quarter Results 2Health News:Defining the Value of Medicine in an Evidence-Based Healthcare Marketplace 2Health News:Defining the Value of Medicine in an Evidence-Based Healthcare Marketplace 3Health News:Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales 2Health News:Pharmasset Appoints Patrick T. Higgins as Executive Vice President, Marketing & Sales 3
Inquire...
Glucose tubes contain an anti-coagulant and a stabiliser. The tubes are ideal for glucose and lactate determinations....
BD Vacutainer® Fluoride Tubes - Glass...
VACUETTE Trace Element tubes - Ridged (safety screw cap) are designed to test trace elements such as Cu, Zn, Pb, etc....
Medicine Products: